SJ Medical
SJ Medical
Explore our core high-precision surgical catheters, guidewires, and biodegradable polymer scaffolds
Understanding the macroeconomic drivers, clinical demands, and global supply chains shaping the interventional cardiology device industry.
The global market for interventional cardiology devices, particularly coronary angioplasty systems, is undergoing a profound structural evolution. Cardiovascular Diseases (CVDs) remain the leading cause of mortality globally, representing an estimated 17.9 million lives lost each year according to the World Health Organization. Within this diagnostic cohort, coronary artery disease (CAD) forms the absolute majority. This clinical reality has driven a sustained surge in demands for minimally invasive procedures such as Percutaneous Coronary Intervention (PCI), driving the global coronary angioplasty market to exceed USD 6.5 Billion, with projected compound annual growth rates (CAGR) maintaining a steady 6.8% path upward through the next decade.
From an industrial perspective, the manufacturing ecosystem is shifting from centralized regional production to diversified, highly resilient global supply hubs. Historically, global supply chains relied on limited contract manufacturers based in North America and Western Europe. However, cost pressures under local reimbursement systems, coupled with requirements for accelerated product development cycles, have prompted major medical device brands to look to advanced, vertically integrated OEM/ODM partners like Hangzhou SJ Medical Co., Ltd. to secure flexible scale, reliable technology baselines, and robust international compliance protocols.
In developing regions across the Asia-Pacific, Latin America, and parts of the Middle East, the clinical volume of balloon angioplasty is scaling up rapidly. This expansion is powered by increased healthcare access, the proliferation of state-run catheterization laboratories (cath labs), and a shift toward value-based procurement. Conversely, mature markets in Europe and North America demand next-generation iterations—focusing heavily on premium trackability, ultra-low profiles for complex calcified lesions, and drug-eluting technologies. To serve both profiles, modern interventional device factories must offer deep OEM capabilities that allow custom configurations of balloon sizes, materials, shaft stiffness, and drug coatings.
Combining decade-long manufacturing experience, advanced material sciences, and clinical insights.
Established in 2015, Hangzhou SJ Medical Co., Ltd. is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Our offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in strict accordance with global GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical assembly and fusion processes.
Our operation is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, we maintain strict quality control and continuously improve our manufacturing processes to ensure ultimate product reliability and consistency.
We strictly adhere to international quality standards. SJ Medical has obtained CE certification, ISO 13485 quality management system certification, and CFDA (NMPA) approval, along with free sale certificates, demonstrating our strong commitment to product quality and international compliance.
How our comprehensive interventional portfolio translates into high-efficiency clinical performance across different medical environments.
In modern interventional cardiology, success depends on the synergy between the access route, guidewire navigation, balloon dilatation dynamics, and downstream therapeutic implants. SJ Medical provides a comprehensive, interconnected product suite designed to resolve challenges faced by interventionalists during complex PCI procedures:
Our Advanced Surgical Introducer Catheter Sheaths and Premium Vascular Access Catheter Sheaths provide smooth arterial entry, reducing insertion force and vascular trauma. The integrated backflow prevention valves ensure zero blood leakage while enabling seamless instrument swaps.
With our PTCA Guidewires (0.014", 180cm) featuring optimized core-to-tip tapers and advanced core wires, clinicians achieve maximum torque control, trackability, and radiopacity. This allows access through calcified lesions and complex bifurcations.
Our Premium High-Pressure Balloon Dilatation Catheters offer controlled expansion with nominal burst pressures, ensuring uniform radial force to crack calcified plaques, prep vessels, and optimize post-stent expansion without risk of dissection.
Beyond traditional metallic stents, SJ Medical is investing in future-oriented technologies including Micro Catheter Precision Nitinol Laser-Cut Thrombectomy Stents for rapid blood flow restoration, and advanced biodegradable biomaterials (Poly Lactic Acid (PLA) and PLGA Microspheres) optimized for drug-delivery systems and bioresorbable tissue engineering scaffolds.
These bioresorbable structures support vascular remodeling during the critical healing phase, then degrade safely into carbon dioxide and water, leaving no foreign implants behind. This technology addresses late-stage stent thrombosis (LST) and chronic vessel irritation.
Pioneering medical engineering with specialized manufacturing machinery and thorough product testing.
As a specialized OEM factory, SJ Medical operates a suite of advanced manufacturing and testing equipment designed specifically for interventional balloon dilatation catheters, guidewires, and delivery systems. Every production phase is executed in class-10,000 clean zones with localized class-100 microenvironments, utilizing top-tier production equipment including:
Our multi-axis automated balloon forming equipment controls stretch speed, temperature profiles, and blow pressure. This enables the fabrication of ultra-thin, high-pressure semi-compliant and non-compliant balloons with walls down to 0.0005 inches.
We use precise laser systems to fuse polymers (such as Pebax, Nylon, and polyurethane) to form transition-free catheter joints. This maximizes push transmission, trackability, and minimizes profile steps for smooth lesion crossability.
Our proprietary UV-cured hydrophilic coating process provides low friction values along the distal shaft. This ensures smooth passage through tortuous coronary pathways while preventing particulate peeling under high-friction conditions.
Optimizing transition joints to reduce profiles to <0.016 inches, while enhancing our hydrophilic coatings to minimize friction coefficient fluctuations during complex multi-stent interventions.
Formulating targeted drug-eluting balloon coatings utilizing biodegradable PLGA carriers to achieve precise drug transfer times (<60 seconds dilatation) with minimal distal embolization risk.
Perfecting the mechanical design of bioresorbable stents to balance radial support with controlled mass degradation, allowing complete physiological vascular restoration over 18 to 24 months.
Answers to critical questions regarding design, material selection, quality control, and regulatory affairs.
Broadening our technology portfolio to support hemodialysis, physiotherapy, and complex orthopedic systems
